Sanofi Forecasts Strong Flu Vaccine Growth, Accelerates COVID Plans

Two-Dose Coronavirus Vaccine Needed Even With Adjuvant

While Dupixent and oncology provide the backbone for future growth, Sanofi could seize an opportunity to expand its vaccines business greatly.

Sanofi_Berlin
• Source: Shutterstock

More from COVID-19

More from Scrip